Adrian Gottschalk - 16 Sep 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Executive Officer, Director
Signature
/s /Allan Reine, M.D., Attorney-in-Fact for Adrian Gottschalk
Issuer symbol
FHTX
Transactions as of
16 Sep 2022
Transactions value $
$21,600
Form type
4
Filing time
19 Sep 2022, 16:06:37 UTC
Previous filing
22 Feb 2023
Next filing
30 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Options Exercise $21.6K +40K +27.31% $0.54* 186K 16 Sep 2022 Direct
holding FHTX Common Stock 325K 16 Sep 2022 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Options Exercise $0 -40K -8.72% $0.00 419K 16 Sep 2022 Common Stock 40K $0.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 300,000 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 25,225 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
F2 The option vested as to 25% of the underlying shares of common stock on May 30, 2018, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option was fully vested.